Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them.

Synthetic Cannabinoid Receptor Agonists (SCRAs) novel psychoactive substances prison system spice drugs violence

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2020
Historique:
received: 18 03 2020
accepted: 06 05 2020
entrez: 13 6 2020
pubmed: 13 6 2020
medline: 13 6 2020
Statut: epublish

Résumé

Novel Psychoactive Substances (NPS), especially Synthetic Cannabinoid Receptor Agonists (SCRAs), pose a substantial challenge to health and the security of the prison environment. This study analyses the phenomenon from the perspective of people in prison and that of professionals working with them. A phenomenological qualitative approach was used to analyze self-reported experiences with 'Spice' (NPS) among users in prison. A semi-structured questionnaire was also disseminated among professionals working in these settings to better understand (a) the impact of NPS on their work; (b) perceived issues on safety in their working environment; (c) approaches used to tackle the phenomenon and best practices. Psychotic events resulting from the collected Spice accounts (5) were marked by hallucinations, depression, self-harm, and suicidal ideations. Other emerging elements included fear, paranoia, inability to be with others, mistrust, breakdown and other risky behaviors. Overall, 186 responses from prison staff were collected across the country. 67% claimed NPS to have had a deep impact on their work as they commonly witnessed espisodes involving outbursts of anger, slurred speech, hallucinations, psychosis, and significant mental deterioration among those in prison. Some 91% have witnessed aggression at least once, with 53% experiencing direct harm. Suggested interventions included enhanced training and education (84%), improved detection (92%) and treatment and support services (93%). Findings highlight the urgent need for joint multi-disciplinary efforts to tackle the exponential escalation of NPS in prisons as well as to facilitate the recovery and societal reintegration of those affected. Phenomenology can be recommended as a valuable methods to study drug induced experiences.

Identifiants

pubmed: 32528329
doi: 10.3389/fpsyt.2020.00460
pmc: PMC7264108
doi:

Types de publication

Journal Article

Langues

eng

Pagination

460

Informations de copyright

Copyright © 2020 Corazza, Coloccini, Marrinan, Vigar, Watkins, Zene, Negri, Aresti, Darke, Rinaldi, Metastasio and Bersani.

Références

Int J Drug Policy. 2017 Feb;40:57-69
pubmed: 27955961
Acta Psychiatr Scand. 2008 Mar;117(3):161-3
pubmed: 18271797
Hum Psychopharmacol. 2017 May;32(3):
pubmed: 28517032
Hum Psychopharmacol. 2017 May;32(3):
pubmed: 28557062
Br J Clin Pharmacol. 2020 Mar;86(3):482-498
pubmed: 31770457
Hum Psychopharmacol. 2017 May;32(3):
pubmed: 28631373
Biomed Res Int. 2014;2014:815424
pubmed: 25133182

Auteurs

Ornella Corazza (O)

Centre for Clinical & Health Research Services, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Sara Coloccini (S)

Centre for Clinical & Health Research Services, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Shanna Marrinan (S)

Centre for Clinical & Health Research Services, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.

Mike Vigar (M)

G4S Care and Justice Services, Swansea, United Kingdom.

Caryl Watkins (C)

G4S Care and Justice Services, Swansea, United Kingdom.

Cosimo Zene (C)

School of History, Religions and Philosophies, University of London (SOAS), London, United Kingdom.

Attilio Negri (A)

Centre for Clinical & Health Research Services, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
School of Pharmacology and Clinical Toxicology, University of Milan, Milan, Italy.

Andreas Aresti (A)

History, Sociology and Criminology, University of Westminster, London, United Kingdom.

Sacha Darke (S)

History, Sociology and Criminology, University of Westminster, London, United Kingdom.

Raffaella Rinaldi (R)

Department of Anatomical, Histological, Forensic and Orthopedic Sciences Departmental Section of Legal Medicine, Sapienza University of Rome, Rome, Italy.

Antonio Metastasio (A)

Centre for Clinical & Health Research Services, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Camden and Islington NHS Trust, London, United Kingdom.

Giuseppe Bersani (G)

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Classifications MeSH